BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5317772)

  • 1. [Hemotherapy in blood coagulation disorders].
    Griffitts JJ
    Bibl Haematol; 1967; 27():294-6. PubMed ID: 5317772
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic materials used in the treatment of coagulation defects.
    Smith JK; Bidwell E
    Clin Haematol; 1979 Feb; 8(1):183-206. PubMed ID: 367662
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and therapy of various form of thrombopathy].
    de Vries SI
    Ned Tijdschr Geneeskd; 1970 Jan; 114(4):154-64. PubMed ID: 4905905
    [No Abstract]   [Full Text] [Related]  

  • 4. [Severe viral hepatitis. Intravascular coagulation and fibrinolysis. Radioisotopic study of the life of platelets and fibrinogens].
    Dechavanne M; Bouletreau P; Petit P
    Presse Med (1893); 1971 Dec; 79(54):2485-6. PubMed ID: 5157899
    [No Abstract]   [Full Text] [Related]  

  • 5. [Transfusion therapy of non-hemophilic hemorrhagic diatheses: thrombopenias, thrombopathies, hemorrhagic thrombocytemias, consumption coagulopathies, anticoagulant induced hemorrhages].
    Fischer M
    Bibl Haematol; 1967; 27():211-27. PubMed ID: 5627946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies of the effectivity of thrombocyte concentrates by nuclear medical and coagulatory physiological methods].
    Preussner S; Frick G; Schulz K; Konrad H; Kiencke H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):55-65. PubMed ID: 4104083
    [No Abstract]   [Full Text] [Related]  

  • 7. [The practical performance of blood platelet transfusion].
    Bucher U; Kummer H
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1635-41. PubMed ID: 5748845
    [No Abstract]   [Full Text] [Related]  

  • 8. Pool's cryoprecipitate and exhausted plasma in the treatment of von Willebrand's disease and factor-XI deficiency.
    Bennett E; Dormandy K
    Lancet; 1966 Oct; 2(7466):731-2. PubMed ID: 4162062
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of Na3-citrate on the solubility of cryoprecipitate (citrate effect on cryoprecipitate).
    Faludi E; Harsányi V
    Haematologia (Budap); 1981; 14(2):207-14. PubMed ID: 6792005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current possibilities for optimal hemotherapy].
    Schneider W; Fröhlich C; Fiedler H
    Z Prakt Anasth; 1971 Aug; 6(4):263-76. PubMed ID: 4111550
    [No Abstract]   [Full Text] [Related]  

  • 11. Blood and blood components in the prevention and control of bleeding.
    Schmidt PJ; Grindon AJ
    JAMA; 1967 Dec; 202(10):967-9. PubMed ID: 5630741
    [No Abstract]   [Full Text] [Related]  

  • 12. Gamma A-gamma G mixed cryoglobulin.
    Matsuhashi T; Usui M; Mizuno N
    Jpn J Exp Med; 1968 Jun; 38(3):205-11. PubMed ID: 4181164
    [No Abstract]   [Full Text] [Related]  

  • 13. [The functional efficiency of thrombocyte concentrates from ACD-preservatives of different ages].
    Beck H; Schmitt H
    Bibl Haematol; 1967; 27():253-6. PubMed ID: 5595090
    [No Abstract]   [Full Text] [Related]  

  • 14. Uses of blood and of blood components.
    Med Lett Drugs Ther; 1972 Nov; 14(24):89-92. PubMed ID: 4648571
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemotasis, coagulation and muscular activities. Preliminary note].
    S'Jongers JJ; Roose P; Rosseeuw D; Demol L; Mondelaers I; Babel J
    Brux Med; 1973 Oct; 53(10):553-9. PubMed ID: 4761148
    [No Abstract]   [Full Text] [Related]  

  • 16. [Substitution of antihemophilic globulin (factor VIII) with special reference to Pool's cold fractionation].
    Matthes M; Engbring H; Winckelmann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(4):434-40. PubMed ID: 4107580
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the spleen retains the youngest and hemostatically most effective platelets.
    Shulman NR; Watkins SP; Itscoitz SB; Students AB
    Trans Assoc Am Physicians; 1968; 81():302-13. PubMed ID: 5721406
    [No Abstract]   [Full Text] [Related]  

  • 19. Rational alternatives to the use of whole blood.
    Westphal RG
    Ann Intern Med; 1972 Jun; 76(6):987-90. PubMed ID: 5027586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Directions for blood component therapy in blood coagulation disorders].
    Rasche H
    Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.